Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About JPET
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About JPET
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

April 01, 1994; Volume 269,Issue 1

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 449;
  • You have access
    In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
    J Imagawa, K Kamei, S Yoshida, I Sugo, T Koga and H Nabata
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 1-6;
  • You have access
    Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
    F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;
  • You have access
    Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
    J Itoh, M Ukai and T Kameyama
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 15-21;
  • You have access
    Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.
    T Colombo, M Zucchetti and M D'Incalci
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 22-27;
  • You have access
    Mefloquine transfer during in vitro human placenta perfusion.
    M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;
  • You have access
    Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
    M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;
  • You have access
    New mechanism of action of the cancer chemotherapeutic agent 5-fluorouracil in human cells.
    J C Wurzer, R J Tallarida and M A Sirover
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 39-43;
  • You have access
    The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
    I Terleckyj and P K Sonsalla
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 44-50;
  • You have access
    Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
    A Sanbe, K Tanonaka, Y Niwano and S Takeo
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 51-56;
  • You have access
    In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
    G Zernig, E R Butelman, J W Lewis, E A Walker and J H Woods
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 57-65;
  • You have access
    K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.
    M T Slawsky and N A Castle
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 66-74;
  • You have access
    Effects of the arachidonate 5-lipoxygenase synthesis inhibitor A-64077 in intestinal ischemia-reperfusion injury.
    M J Mangino, M K Murphy and C B Anderson
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 75-81;
  • You have access
    Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
    C K Kost, W A Herzer, P Li and E K Jackson
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 82-88;
  • You have access
    Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
    P A Cossum, L Truong, S R Owens, P M Markham, J P Shea and S T Crooke
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 89-94;
  • You have access
    Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
    I A Paul, G Nowak, R T Layer, P Popik and P Skolnick
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 95-102;
  • You have access
    Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits.
    W Piekoszewski, F S Chow and W J Jusko
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 103-109;
  • You have access
    5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord.
    K Bervoets and M J Millan
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 110-120;
  • You have access
    5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
    M J Millan, J M Rivet, A Gobert, H Canton, S Veiga and K Bervoets
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 121-131;
  • You have access
    Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    R W Fuller, S K Hemrick-Luecke and H D Snoddy
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 132-136;
  • You have access
    Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion.
    T A Kosten, M J Miserendino, S Chi and E J Nestler
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 137-144;
  • You have access
    Protein binding of tirilazad (U-74006) in human, Sprague-Dawley rat, beagle dog and cynomolgus monkey serum.
    P A Bombardt, J E Brewer and M G Johnson
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 145-150;
  • You have access
    Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
    W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;
  • You have access
    Selective effects of alcohols on gamma-aminobutyric acid A receptor subunits expressed in human embryonic kidney cells.
    W Marszalec, Y Kurata, B J Hamilton, D B Carter and T Narahashi
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 157-163;
  • You have access
    Dual action of the cyclodiene insecticide dieldrin on the gamma-aminobutyric acid receptor-chloride channel complex of rat dorsal root ganglion neurons.
    K Nagata and T Narahashi
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 164-171;
  • You have access
    A novel phospholipase C inhibitor and phorbol esters reveal selective regulation of thrombin- and parathyroid hormone-stimulated signaling pathways in rat osteosarcoma cells.
    M Babich, G E Alford and R A Nissenson
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 172-177;
  • You have access
    Resting state block and use independence of rat vascular muscle Ca++ channels by Ro 40-5967.
    S K Mishra and K Hermsmeyer
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 178-183;
  • You have access
    Quantitative trait loci mapping of genes that influence the sensitivity and tolerance to ethanol-induced hypothermia in BXD recombinant inbred mice.
    J C Crabbe, J K Belknap, S R Mitchell and L I Crawshaw
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 184-192;
  • You have access
    ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
    S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;
  • You have access
    Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression.
    C C Chao, G Gekker, W S Sheng, S Hu, M Tsang and P K Peterson
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 198-203;
  • You have access
    Effect of phenylisothiocyanate on organic cation transport in opossum kidney cells.
    R J Ott, J K Chan, V K Ramanathan, A C Hui and K M Giacomini
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 204-208;
  • You have access
    Inhibition of a K+ current by beta-dendrotoxin in primary and subcultured vascular smooth muscle cells.
    J Ren, E Karpinski and C G Benishin
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 209-214;
  • You have access
    Renal functional responses to the 5-HT1A receptor agonist flesinoxan: effects of controlled renal perfusion pressure.
    A L Chamienia and E J Johns
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 215-220;
  • You have access
    Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels.
    M Endou, E Poli and R Levi
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 221-229;
  • You have access
    Effects of nitric oxide-related agents on rat testicular function.
    M L Adams, E R Meyer, B N Sewing and T J Cicero
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 230-237;
  • You have access
    A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
    P Salvati, L Dho, G Ukmar, L Vaga, O Rimoldi and C Patrono
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 238-245;
  • You have access
    Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.
    C D Unsworth and P B Molinoff
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 246-255;
  • You have access
    Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
    L L Simpson, J A Coffield and N Bakry
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 256-262;
  • You have access
    Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
    A A Seymour, J H Sheldon, P L Smith, M Asaad and W L Rogers
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 263-270;
  • You have access
    Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
    H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
  • You have access
    Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
    F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;
  • You have access
    Structural and functional consequences of minoxidil-induced cardiac hypertrophy.
    C S Moravec, T Ruhe, J R Cifani, M Milovanovic and P A Khairallah
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 290-296;
  • You have access
    The critical role of the rate of ethanol absorption in the interpretation of studies purporting to demonstrate gastric metabolism of ethanol.
    M D Levitt and D G Levitt
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 297-304;
  • You have access
    Adrenergic and nonadrenergic regulation of hindlimb blood flow during stress in rats.
    R H Alper and M H Zink
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 305-312;
  • You have access
    Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra.
    J Zhang, L A Chiodo and A S Freeman
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 313-321;
  • You have access
    Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
    S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;
  • You have access
    Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
    R A Huff, J J Corcoran, J K Anderson and M B Abou-Donia
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 329-335;
  • You have access
    Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification.
    A Zaza, G Malfatto and P J Schwartz
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 336-343;
  • You have access
    Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
    Y S Kang and W M Pardridge
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 344-350;
  • You have access
    Differences in beta adrenergic receptor agonist affinity between cardiac myocytes and coronary arterioles in canine heart.
    L Cooke and K H Muntz
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 351-357;
  • You have access
    Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
    J B Long, D D Rigamonti, M A Oleshansky, C P Wingfield and A Martinez-Arizala
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 358-366;
  • You have access
    Tumor necrosis factor: receptor binding and expression of receptors in cultured mouse hepatocytes.
    G M Adamson and R E Billings
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 367-373;
  • You have access
    Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
    L H Lash, P J Sausen, R J Duescher, A J Cooley and A A Elfarra
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 374-383;
  • You have access
    Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
    R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;
  • You have access
    The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neurons.
    M Weller, A M Marini, B Martin and S M Paul
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 393-401;
  • You have access
    Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells.
    R K Dubey
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 402-408;
  • You have access
    The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate.
    G E Billman
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 409-416;
  • You have access
    Developmental expression of human microsomal epoxide hydrolase.
    C J Omiecinski, L Aicher and L Swenson
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 417-423;
  • You have access
    Quantification of the calcium antagonism of lacidipine by kinetic analysis.
    A Giacometti, D Micheli, G Gaviraghi and D G Trist
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 424-429;
  • You have access
    Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
    L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;
  • You have access
    Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.
    M A Klitenick and P W Kalivas
    Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 437-448;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 269, Issue 1
1 Apr 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Read
Loading
  • NAD+ and Vitamin B3: From Metabolism to Therapies
  • Role of Tyrosine Kinase Inhibitors in Cancer Therapy
  • Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma
  • Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability
  • Canagliflozin Actions on Sodium/Glucose Cotransporters
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2018 by the American Society for Pharmacology and Experimental Therapeutics